Table 1.
Category | Compounds |
---|---|
Kinase and phosphatase inhibitors | |
TGF-β receptor inhibitor | CB 41227199a |
Protein kinase A and B inhibitor | CB 97929926 |
Protein kinase C inhibitor | calphostin C |
Thymidine kinase inhibitor | CB 17846240 |
Cyclin-dependent kinase inhibitors | CB 42005171, CB 20372475, CB 14126598 |
IκB kinase inhibitors | CB 15143266, CB 28324237 |
c-Jun N-terminal kinase 3 inhibitor | CB 34431373 |
ERBB2 kinase inhibitor | tyrphostin AG-825 |
RAF kinase inhibitor | CB 14171361 |
SRC kinase inhibitor | CB 14280993 |
CD45 phosphatase inhibitor | RWJ-60475-(AM)3 |
Bioactive lipids, modulators of lipid metabolism or signaling | |
Omega-3, 6, 9 fatty acids | eicosatrienoic acid (20:3 n-3) (11,14,17-ETE) docosahexenoic (22:6, n-3) (4,7,10,13,16,19-DHA) arachidonic acid (20:4, n-6) (5,8,11,14-AA) eicosatriynoic acid (20:3, n-9) (5,8,11-ETI) |
Cyclooxygenase inhibitors | indomethacin, indoprofen |
Lipoxygenase metabolite | 12(R) = HETE |
Prostaglandins | PGD2; 13,14-Dihydro-PGE1; 17-phenyl-trinor-PGE2; 9B,11A-PGF2 |
Leukotriene B4 antagonist | U-75302 |
Ion channel modulators and ionophores | |
Potassium channel openers | cloxyquin, minoxidil, rottlerin |
Calcium ionophore | ionomycin |
Nuclear hormone receptor inhibitors | |
Liver × receptor inhibitor | CB 78238822 |
Retinoic acid receptor inhibitors | CB 70700976, CB 82029493 |
Other signaling modulators | |
Nuclear factor κB (NF-κB) inhibitor | caffeic acid phenethyl ester |
Adenosine A3 receptor agonist | IB-MECA |
Phosphodiesterase inhibitors | zardaverine, dyphylline |
Histamine H1 receptor antagonists | doxylamine succinate, carbinoxamine maleate |
Antimicrobials | fusidic acid, chloroxylenol, nitrofurantoin |
Other | N-Acetyl-S-geranyl-L-cysteine, guanethidine sulfate, roxarsone, glucosamine hydrochloride, guaifenesin, lactulose, alrestatin |
Four compound libraries were screened, and hits (right column) were binned into categories (left column) based on biological activities.
One hit, CB 41227199, highlighted the importance of TGF-β signaling in PAA angioblast differentiation.